Oak Thistle’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-7,676
Closed -$600K – 590
2026
Q2
$600K Buy
+7,676
New +$619K 0.06% 414
2026
Q1
– Sell
-14,418
Closed -$1.38M – 572
2025
Q4
$1.38M Buy
+14,418
New +$1.4M 0.19% 224
2025
Q2
– Sell
-43,359
Closed -$3.9M – 549
2025
Q1
$3.9M Buy
43,359
+27,494
+173% +$2.46M 0.78% 14
2024
Q4
$1.27M Buy
+15,865
New +$1.37M 0.38% 82
2024
Q3
– Sell
-5,898
Closed -$464K – 482
2024
Q2
$464K Buy
+5,898
New +$484K 0.34% 122
2022
Q1
– Sell
-9,357
Closed -$968K – 467
2021
Q4
$968K Buy
+9,357
New +$1.08M 0.75% 7

Other funds holding MDT

Oak Thistle's MDT Position: Q3 2026 in Review

Oak Thistle sold out of Medtronic (MDT) in Q3 2026, closing a stake of 7,676 shares — an estimated $600K sold.

Oak Thistle first reported a position in MDT in Q4 2021 and held it in 6 quarters. The position peaked at $3.9M in Q1 2025. 1,900 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Oak Thistle reported no remaining Medtronic position as of Q3 2026 after selling out during the quarter.
  • Oak Thistle sold 7,676 Medtronic shares in Q3 2026, an estimated $600K.
  • Oak Thistle first reported a position in Medtronic in Q4 2021 and held it in 6 quarters.
  • Oak Thistle's Medtronic position peaked at $3.9M in Q1 2025.
  • 1,900 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Oak Thistle's 13F filing for Q3 2026, filed 21 Oct 2026.